Notably, a significant positive correlation in all study population was observed (p < 0.0001, Fig. 1C) between the hepatic mRNA levels of BMP2 and CD36, a fatty acid transporter which contributes to liver fat accumulation in patients with NAFLD [22]. The gene discussed is CD36; the disease is metabolic dysfunction-associated steatotic liver disease.